Bicara Therapeutics (BCAX) Prepaid Assets (2023 - 2026)
Bicara Therapeutics' (BCAX) quarterly Prepaid Assets came in at $5.2 million in Q1 2026, down 40.59% year-on-year from $8.7 million in Q1 2025, and down 28.82% quarter-over-quarter from $7.3 million in Q4 2025.
Bicara Therapeutics (BCAX) Prepaid Assets (2023 - 2026) Analysis & Trends
Bicara Therapeutics' Prepaid Assets history runs 4 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 40.59% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 40.59% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, down 43.44% from the prior year.
- Prepaid Assets eased to $5.2 million in Q1 2026 per BCAX's latest filing, from $7.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $12.8 million in Q4 2024 and bottomed at $633000.0 in Q4 2023.
- The 4-year median for Prepaid Assets is $7.2 million (2025), against an average of $6.3 million.
- Across the five-year window, Prepaid Assets surged 1925.59% in 2024 and slumped 43.44% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $633000.0 in 2023, then jumped by 1925.59% to $12.8 million in 2024, then tumbled by 43.44% to $7.3 million in 2025, then declined by 28.82% to $5.2 million in 2026.
- Per Business Quant, the three latest BCAX Prepaid Assets figures stand at $5.2 million (Q1 2026), $7.3 million (Q4 2025), and $7.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Bicara Therapeutics | 1.64 Bn | 1.64 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 7.21 Mn |
| Jun 30, 2025 | 7.79 Mn |
| Mar 31, 2025 | 8.69 Mn |
| Dec 31, 2024 | 12.82 Mn |
| Sep 30, 2024 | 756,000.00 |
| Dec 31, 2023 | 633,000.00 |